Rosa Seminario reviews Massive Bio content as part of our Medical Review Board, ensuring medical accuracy and clinical currency across our cancer resources.
Content reviewed by Rosa Seminario
Polycythemia Vera and Myelofibrosis
MARCH 2022
Life Expectancy in Myelofibrosis
MARCH 2022
Pancreatic Cancer Detection, Diagnosis, and Staging
MARCH 2022
Genomic Testing for Cancer Biomarkers FAQs
JULY 2021
Non Small Cell Lung Cancer Prognosis
MAY 2021
What is ALK Positive?
APRIL 2021
Dr. Selin Kurnaz Startup Success with Panwar – Massive Bio
JANUARY 2021
Myelofibrosis Clinical Trials
JANUARY 2021
Prostate Cancer Clinical Trials
JANUARY 2021
Signs of Colon Cancer
DECEMBER 2020
Blood Cancer
NOVEMBER 2020
Follicular Lymphoma Treatment
NOVEMBER 2020
What Does Early Access In Cancer Care Mean?
OCTOBER 2020
Cervical Cancer Risk Factors
SEPTEMBER 2020
Cervical Cancer Symptoms and Signs
SEPTEMBER 2020
Cancer Biomarkers
JULY 2020
What is Genomic Testing in Cancer Treatment?
JUNE 2020
Stage 4 Cervical Cancer Clinical Trials
MAY 2020
Interview: Selin Kurnaz, Massive Bio
MARCH 2020
SYNERGY-AI Trial Presentation at ASCO – Massive Bio
JANUARY 2019
No articles match your search.